Navigation Links
Mast Therapeutics Announces Management Change
Date:8/29/2014

l studies, partner its product candidates at inopportune times or pursue less expensive but higher-risk and/or lower return development paths if it is unable to raise sufficient additional capital as needed; the risk that, even if the Company successfully develops a product candidate in one or more indications, it may not realize commercial success with its products and may never generate revenue sufficient to achieve profitability; the risk that the Company is not able to adequately protect its intellectual property rights relating to the MAST platform and MST-188 or AIR001 and prevent competitors from duplicating or developing equivalent versions of its product candidates; and other risks and uncertainties more fully described in the Company's press releases and periodic filings with the Securities and Exchange Commission. The Company's public filings with the Securities and Exchange Commission are available at www.sec.gov.

You are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date when made. Mast Therapeutics does not intend to revise or update any forward-looking statement set forth in this press release to reflect events or circumstances arising after the date hereof, except as may be required by law.

Logo - http://photos.prnewswire.com/prnh/20120612/LA22456LOGO-a


'/>"/>
SOURCE Mast Therapeutics
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
2. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
3. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
4. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
5. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
6. Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland
7. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
8. Cara Therapeutics Licenses Novel Kappa Opioid Agonist, CR845, to Chong Kun Dang Pharmaceutical Corporation For South Korean Market
9. Frost & Sullivan: High Uptake of New Drug Therapies and Aging Population Expansion Keep the U.S. Retinal Therapeutics Market Buoyant
10. Zenobia Therapeutics, Inc. And BioBlocks, Inc. Announce Sale Of A Joint Fragment Library Ideal For Screening By All Popular Methods
11. New Forecast Shows Global Protein Therapeutics Market to Reach $143.4 Billion by 2015
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... , April 21, 2015 The saturated European ... from the rising incidence of preterm births. This trend ... care unit (NICU) devices but also skilled and trained ... from Frost & Sullivan, Analysis of the Western European ... revenues of $151.5 million in 2014 and estimates this ...
(Date:4/21/2015)... April 21, 2015 EUSA Pharma ... reach, today announced the appointment of Lee Morley ... as a Non-Executive Director.  Bryan Morton, who established EUSA ... Chairman.   Lee Morley joins ... President, Head of Commercial for Europe ...
(Date:4/21/2015)... April 21, 2015  Legal-Bay LLC, The Lawsuit ... Boehringer Ingelheim Pharmaceuticals, is seeking FDA approval for ... According to PBR, Boehringer submitted a supplemental new ... that Pradaxa will be approved for the prophylaxis ... (PE) for patients who have undergone a primary ...
Breaking Medicine Technology:Rising Numbers of Preterm Births Stoke Demand for Infant Care Solutions in Europe 2Rising Numbers of Preterm Births Stoke Demand for Infant Care Solutions in Europe 3EUSA Pharma Appoints Lee Morley as Chief Executive and Industry Veteran Göran Ando to Board of Directors 2EUSA Pharma Appoints Lee Morley as Chief Executive and Industry Veteran Göran Ando to Board of Directors 3Pradaxa Maker Boehringer Ingelheim Pharmaceuticals Pursues Pradaxa FDA Approval to treat DVT and PE 2Pradaxa Maker Boehringer Ingelheim Pharmaceuticals Pursues Pradaxa FDA Approval to treat DVT and PE 3
... SARcode Corporation presented data today for their lead investigational ... trial, subjects receiving SAR 1118 demonstrated a reduction in ... as compared to placebo. These data were part of ... Vision and Ophthalmology (ARVO) Annual Meeting held in Fort ...
... 3, 2011 At the Board of Directors meeting held ... per share. The dividend is payable on June 15, 2011 ... About Sigma-Aldrich: Sigma-Aldrich is a leading ... to Improve the Quality of Life. Its chemical and biochemical ...
Cached Medicine Technology:SAR 1118 Demonstrates Encouraging Results in Phase 2 Study of Dry Eye Disease 2SAR 1118 Demonstrates Encouraging Results in Phase 2 Study of Dry Eye Disease 3
(Date:4/21/2015)... United Benefit Advisors (UBA), the nation’s ... to welcome Power Kunkle Benefits Consulting as its ... Jeff Power have been committed to providing the ... more than 450 clients. For Power Kunkle Benefits ... stewardship, ethical consulting, and measurable results. , ...
(Date:4/21/2015)... 2015 Atlantic Information Services, Inc. ... Medicare-Medicaid Dual Eligibles Database, a brand-new, continually updated ... to the more than 9 million Medicare-Medicaid dual ... than $300 billion in annual health care spending. ... team that also creates the industry-leading AIS’s Directory ...
(Date:4/21/2015)... Nashville, Tenn. – Radsource, a leader ... Archiving and Communication Systems (PACS), has expanded its ... the first quarter of 2015. , Kentucky Breast ... and Lowcountry Orthopaedics & Sports Medicine (Charleston, SC) ... services. Mt. San Rafael Hospital (Trinidad, CO) will ...
(Date:4/21/2015)... eSight is the only technology in the world that ... Tuesday, May 5th, Low Vision Specialists of Maryland and ... an unveiling and demonstration of the technology at 8:30 a.m ... will be the first ophthalmic practice in Maryland to offer ... will be available on the day of the unveiling. , ...
(Date:4/21/2015)... 2015 With a growing number of ... Worldwide indicates that international political instability and terrorism top ... survey by Clements, a global insurance provider with 68 ... their country of citizenship, also found strong concern but ... health care insurance overseas . , Asked to choose ...
Breaking Medicine News(10 mins):Health News:Power Kunkle Benefits Consulting Is the Latest Partner Firm To Join United Benefit Advisors 2Health News:New AIS Database Tracks All Programs, Plans Serving the Dual-Eligible Community 2Health News:Radsource Adds 4 ProtonPACS Clients in 1st Quarter 2Health News:eSight Electronic Glasses That Enable The Legally Blind To See – First In The World – Coming To Maryland 2Health News:eSight Electronic Glasses That Enable The Legally Blind To See – First In The World – Coming To Maryland 3Health News:Potential Expatriate Retirees Fear Political Violence, International Health Insurance Coverage 2Health News:Potential Expatriate Retirees Fear Political Violence, International Health Insurance Coverage 3
... types of blood pressures -- systolic pressure is created by ... the vessels and diastolic pressure is when the heart is ... is 120/80. The first number in a blood pressure reading ... is the diastolic pressure. ,A recent study shows ...
... According to a recent study conducted researchers suggest that ... from // having their tonsils and adenoids out. ... States. Most of the time, it is performed to ... however, doctors have also used the surgery to treat ...
... of hospitalization among people 65 or older but is ... heart damage or complications and the costs of care. ... test for high levels of the peptide in patients ... have congestive heart failure, in which the heart stops ...
... cancer in the United States. According to a recent study ... In addition, soy protein may help minimize the number and ... diets to female mice and followed their progress for one ... specific ingredients. Diet one contained milk protein, and diet two ...
... Previous studies show conflicting results over whether hormone replacement ... A recent study examines the pros and cons of ... combined HRT therapy for five years. All the women ... had menopausal symptoms, while others did not.Results show women ...
... with 32,800 middle-aged women has shown that there may be ... no risk factors whose blood has high amounts of iron.// ... in 1989-90 from women with no history of diabetes, cardiovascular ... had shown an average iron concentration of 109 nanograms/milliliter manifested ...
Cached Medicine News:Health News:Study On Self Measurement Of Blood Pressure 2Health News:‘Protein’ Produced By Overstressed Heart Muscle a Strong Indicator Of Heart Disea 2
9 mm slightly curved blade. Hexagonal handle....
9 mm blade....
4 mm disposable bevel blade. Malleable shafts. Flat spot on handle designed to guide knife in perforation....
Storz Ear Knife Handle....
Medicine Products: